To establish a pharmaceutical bio-innovation committee

Yoon Suk-youl promised,

The goal of establishing an organization directly under the Prime Minister and becoming a pharmaceutical bio powerhouse

COVID-19 quarantine measures, complete reorganization within 100 days of power

Yoon Suk-youl, presidential candidate for the presidential election, pledged to establish a "pharmaceutical bio-innovation committee" directly under the Prime Minister, while creating an ecosystem that can establish sovereignty in pharmaceutical bio and foster key talents and jobs in the pharmaceutical bio industry.

 

It is said that it will overhaul the COVID-19 response system within 100 days immediately after taking office and implement the national responsibility system for vaccine side effects.

 

The pledge also included strengthening access to medicines for patients by diversifying the rapid benefit registration system for drugs with severe rare diseases such as ultra-high-priced anticancer drugs compared to the previous one.

 

On the 24th, Candidate Yoon Suk-youl announced a policy pledge for the power of the people in the 20th presidential election.

 

Candidate Yoon said he would use the health care and pharmaceutical bio-industry as a new path to establishing health security and creating national wealth.

 

He specified in his pledge the establishment of a "pharmaceutical bio-innovation committee" directly under the Prime Minister in line with the establishment of a pharmaceutical bio-control tower directly under the Blue House demanded by the KRPIA.

 

In addition, the vision is to support national R&D to establish vaccine sovereignty and global vaccine hubs and to establish an environment to expand talent and jobs in the pharmaceutical bio industry.

 

◆ Reorganization of the Infectious Disease Response System = Yoon said the current government failed to respond to COVID-19.

 

They say that they have failed to establish a proper treatment system while causing unnecessary economic damage and prolonging damage to small business owners and self-employed people by keeping distance without principles.

 

In response, candidate Yoon plans to completely reorganize the COVID-19 response system within 100 days.

 

The pledges include scientific and data-based quarantine measures, reorganization of the manual for responding to new infectious diseases, and conversion of public medical institutions to hospitals dedicated to COVID-19.

 

It also declared that it will open the era of biohealth and become a vaccine and treatment powerhouse.

 

He criticized that six domestic vaccines are currently undergoing clinical trials, but have nothing to do with government support.

 

It is pointed out that the SK Bioscience vaccine, which is in phase 3 of clinical trials, is also being developed with technical cooperation and the CEPI support at the University of Washington in the United States.

 

He promised to expand the overall national R&D, including high-speed vaccine development and manufacturing technology, post-corona vaccines and treatments, essential vaccines, and digital quarantine.

 

The government's responsibility system for essential medical care and the national responsibility system for side effects of COVID-19 vaccination were included in the pledge.

 

Under the public policy fee system, policy fees added compared to usual times are paid to doctors and nurses in emergency situations such as COVID-19, and public policy fees are also paid to severe trauma centers, delivery rooms, and newborn rooms.

 

◆ National Health Protection = Candidate Yoon also pledged to expand support for disaster medical expenses, ease the burden of national nursing expenses, and introduce a rapid registration system for expensive anticancer drugs and new drugs for severe and rare diseases.

 

Among them, the rapid registration system of expensive anticancer drugs and new drugs for severe and rare diseases is a policy proposal that the KRPIA strongly appealed to when it met with party leader Lee Joon-seok.

 

Candidate Yoon said that it takes about two years to pay health insurance benefits for new drugs with severe rare diseases such as cancer, and patients are paying high prices and administering new drugs.

 

RSA also pointed out that it was applied only to 41 drugs, and 32 of them were concentrated on anticancer drugs.

 

Candidate Yoon promised to shorten the health insurance registration process for anticancer drugs and treatments for severe rare diseases.

 

It also said it will use RSA to reduce drug price negotiations and the burden on patients and insurers.

 

In order to secure insufficient emergency and essential medical care and medical personnel in the region, the government will strengthen the publicity of local national university hospitals and upper-level general hospitals and expand them to cities and provinces without upper-level general hospitals.